Temporal variation in nephrotoxicity of low doses of isepamicin in rats

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 802-806

  Yoshiyama, Yuji ^a   Grenier, Louis ^b,c   Gourde, Pierrette ^b,c   Simard, Marie ^b,c   Lin, Lesheng ^b,c   Morin, Nathalie J ^b,c   Bergeron, Michel G ^b,c   Labrecque, Gaston ^b   Beauchamp, Denis ^b,c  

^a KEIO UNIVERSITY   (Japan)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; ISEPAMICIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY TUBULE CELL; LIVER REGENERATION; LYSOSOME; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RAT;

EID: 0030067773     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.802     Document Type: Article

References (39)

1. Bates, R. D., and M. C. Nahata. 1994. Once-daily administration of ammoglycosides. Ann. Pharmacother. 28:757-765.
2. Beauchamp, D., P. Gourde, and M, G. Bergeron. 1991. Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 35:2173-2179
3. Beauchamp, D., G. Laurent, P. Maldague, S. Abid, B. K. Kishore, and P. M. Tulkens. 1990. Protection against gentamicin-induced early renal alterations (phospholipidosis, increased DNA synthesis) by co-administration of polyaspartic acid. J. Pharmacol. Exp. Ther. 255:858-866.
4. Beauchamp, D., M. Pellerin, P. Gourde, M. Pettigrew, and M. G. Bergeron. 1990. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob. Agents Chemother 34:139-147.
5. Bendayan, M., and M. Zollinger. 1983. Ultrastructural localization of antigenic sites on osmium-fixed tissue applying the protein A-gold technique. J. Histochem. Cytochem. 31:101-109.
6. Bennett, W. M., W. C. Elliott, D. C. Houghton, D. N. Gilbert, J. Defehr, and D. A. McCarron. 1982. Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob. Agents Chemother 22:508-512.
7. Bennett, W. M., C. E. Plamp, D. N. Gilbert, R. A. Parker, and G. A. Porter. 1979. The influence of dosage regimen on experimental gentamicin nephroloxicity. dissociation of peak serum levels from renal failure. J. Infect. Dis 140:576-580
8. Dorian, C., P. Cantroux, and J. Canibar. 1987. Étude de la chrononéphrotoxicité de l'amikacine après intoxication chronique de 7 jours chez le rat Pathol. Biol 35:735-738.
9. Fantin, B., B. Pangon, G. Potel, J. M. Vallois, F. Caron. A. Bure, and C. Carbon. 1989 Ceftriaxone-netilmicin combination in single-daily dose treatment of experimental Escherichia coli endocarditis. Antimicrob. Agents Chemother. 33:767-770
10. Francioli, P. B., and M. P. Glauser. 1993. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37:207-212
11. Fujimura, A., T. Sudoh, and A. Ebihara. 1994. Time-dependent change in the toxic effects of amikacin on renal functions. Life Sci. 55:367-372.
12. Gilbert, D. N., C. A. Wood, S. J. Kohlhepp, P. W. Kohnen, D. C. Houghton, H. C. Finkbeiner, J. Lindsley, and W. M. Bennett. 1989. Polyaspartic acid prevents experimental aminoglycosides nephrotoxicity. J. Infect. Dis 159: 945-953.
13. Hosokawa, H., S. Nyu, K. Nakamura, K. Mifune, and S. Nakano. 1993. Cireadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression. Chronobiol. Int. 10: 259-270.
14. Humes, H. D., M. Sastrasinh, and J. M. Weinberg. 1984 Calcium is a competitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. J. Clin. Invest. 73:135-147.
15. Kabins, S. A., and C. Nathan. 1978. In vitro activity of SCH 21420, derivative of gentamicin B. compared to that of amikacin. Antimicrob. Agents Chemother. 14:786-787.
16. Kacew, S. 1989. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5′ phosphate in the rat. J Pharmacol. Exp. Ther. 248:360-366.
17. Kishorc, B. K., Z. Kallay, P. Lambricht, G. Laurent, and P. M. Tulkens. 1990. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. J. Pharmacol Exp. Ther. 255:1-8
18. Laurent, G., P. Maldague, M. B. Carlier, and P. M. Tulkens. 1983. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother. 24:586-593.
19. Lee, S. M., and U. F. Michael. 1985. The protective effect of nitrodepine on gentamicin acute renal failure in rals. Exp. Med. Pathol. 43:107-114.
20. Liu, L., L. Grenier, Y. Bergeron, M. Simard, M. G. Bergeron, G. Labrecque, and D. Beauchamp. 1994. Temporal changes of pharmacokinetics. nephrotoxicity. and subcellular distribution of tobramycin in rats. Antimicrob Agents Chemother. 38:54-60.
21. Lin, L., L. Grenier, G. Thériault, P. Gourde, M. G. Bergeron, G. Labrecque, and D. Beauchamp. 1994. Chrononephrotoxicity of low doses of tobramycin in rats. Life Sci. 55:169-177.
22. Lucht, F., S. Tigaud, G. Esposito, J. Cougnard, M. P. Fargier, D. Peyramond, and J. L. Bertrand. 1990. Chronokinetic study of netilmicin in man. Eur J. Clin. Pharmacol. 39:199-201.
23. Matsumoto, T., J. Kumazawa, S. Ueda, K. Eto, Y. Yushita, Y. Saito, T. Ishii, and Y. Sawae. 1991. Treatment of complicated urinary tract infections with ofloxacin following an aminoglycoside. Chemotherapy 37:60-71.
24. Minguez, F., M. Agra, S. Luruena, C. Ramos, and J. Prieto. 1990 Postantibiotic effect of isepamicin compared to that of other aminoglycosides. Drugs Exp. Clin. Res. 16:231-251.
25. Nakano, S., and N. Ogawa. 1990. Chronotoxicity of gentamicin in mice. IRCS Med. Sci. 10:592-593.
26. Nakano, S., J. Song, and N. Ogawa. 1990. Chronopharmacokinetics of gentamicin. comparison between man and mice. Annu Rev. Chronopharmacol. 7:277-280
27. Pariat, C., P. Courtois, J. Cambar, A. Piriou, and S. Bouquet. 1988. Cireadian variations in the renal toxicology of gentamicin in rats. Toxicol. Lett 40:175-182.
28. Potel, G., N. P. Chau, B. Fangon, B. Fantin, J. M. Vallois, F. Faurisson, and C. Carbon. 1991. Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. Antimicrob. Agents Chemother 35:2085-2090.
29. Powell, S. H., W. L. Thompson, M. A. Luthe, R. C. Stern, D. A. Grossniklaus, D. D. Bloxham, and J. D. Klinger. 1983. Once-daily vs continuous aminogly coside dosing: efficacy and toxicity in animal and clinical studies of gentamicin. netilmicin and tobiamycin J. Infect. Dis. 147:918-932.
30. Rankin, L. I., F. C. Luft, M. N. Yum, R. S. Sloan, C. B. Dinwiddie, Jr., and L. L. Isaacs. 1979, Comparative nephrotoxicity of SCH 21420 and amikacin in rats Antimicrob, Agents Chemother 16:491-494
31. Sanders, S. C., W. E. Sanders, and R. V. Goering. 1978. In vitro studies with SCH 21420 and SCH 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci Antimicrob. Agents Chemother. 14:178-184.
32. Song, J., S. Ohdo, N. Ogawa, and S. Nakano. 1993. Influence of feeding schedule on chronopharmacological aspects of gentamicin in mice. Chronobiol. Int. 10:338-348
33. Suzuki, K., M. Horiba, and V. Nagata. 1990. Pharmacokinetic and clinical studies on isepamicin in chronic complicated urinary tract infection using daily single dose treatment Jpn. J. Antibiot. 43:1649-1659.
34. Takumida, M., I. Nishida, M. Nikaido, K, Hirakawa, Y. Harada, and D. Bagger-Sjoback. 1990. Effect of dosing schedule on ammoglycoside ototoxicity. comparative cochlear ototoxicity of amikacin and isepamicin. ORI. J. Oto-Rhino-Lary. 52:341-349.
35. Wood, C. A., H. Finkbeiner, S. J. Kohlhepp, P. W. Kohnen, and D. N. Gilbert. 1989. influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother. 33:1280-1285.
36. Yoshiyama, Y., T. Kobayashi, S. Ohdo, N. Ogawa, M. G. Bergeron, G. Labrecque, D. Beauchamp, and S. Nakano. Time-dependent changes of pharmacokinetics of isepamicin in man. J. Infect Chemother., in press
37. Yoshiyama, Y., T. Kobayashi, F. Tomonaga, and S. Nakano. 1992. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J. Antibiot 45: 806-808.
38. Yoshiyama, Y., S. Nishikawa, T. Sugiyama, T. Kobayashi, H. Shimada, F. Tomonaga, S. Ohdo, N. Ogawa, and S. Nakano. 1993. Influence of circadianstage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob. Agents Chemother 37:2042-2043
39. Yu, P. K. W., and J. A. Washington. 1978. In vitro evaluation of a semisynthetic derivative of gentamicin B (SCH 21420). Antimicrob. Agents Chemother 13:891-892.